|
|
|
Volumn 6, Issue 22 SUPPL., 2000, Pages
|
|
Alzheimer's disease: Clinical treatment options
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
ASCORBIC ACID;
CHOLINESTERASE INHIBITOR;
CITALOPRAM;
DONEPEZIL;
ESTROGEN;
FLUOXETINE;
FLUVOXAMINE;
GALANTAMINE;
GINKGO BILOBA EXTRACT;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OLANZAPINE;
PREDNISONE;
RISPERIDONE;
RIVASTIGMINE;
SELEGILINE;
SERTRALINE;
TACRINE;
UBIQUINONE;
VALPROATE SEMISODIUM;
ALZHEIMER DISEASE;
BEHAVIOR DISORDER;
CAREGIVER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DISEASE ASSOCIATION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESPONSE;
EXTRAPYRAMIDAL SYMPTOM;
FUNCTIONAL DISEASE;
GASTROINTESTINAL SYMPTOM;
HOSPITAL ADMISSION;
HUMAN;
LONG TERM CARE;
NEUROPROTECTION;
NURSING HOME;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
SOMNOLENCE;
SUPPORT GROUP;
TREATMENT FAILURE;
TREATMENT PLANNING;
AGED;
ALZHEIMER DISEASE;
ANTICONVULSANTS;
ANTIDEPRESSIVE AGENTS;
ANTIOXIDANTS;
ANTIPSYCHOTIC AGENTS;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
DISEASE PROGRESSION;
ESTROGENS;
HUMANS;
NOOTROPIC AGENTS;
UNITED STATES;
VITAMIN E;
|
|
EID: 0034522014
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (25)
|
